Epileptiform activity in the limbic system

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 2, 2011, Pages 565-593

  Oliveira, Mauro Schneider ^a   Otalora, Luis Fernando Pacheco ^b   Mello, Carlos Fernando ^c   Cavalheiro, Esper Abrao ^d   Garrido Sanabria, Emilio Rafael ^b  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^b UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Channelopathy; Electrophysiology; Epilepsy; Pilocarpine; Review; Voltage gated ion channel

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOPYRIDINE; ANTICONVULSIVE AGENT; BICUCULLINE; CALCIUM ION; DIAZEPAM; ETIRACETAM; EXCITOTOXIN; ION CHANNEL; KAINIC ACID; KAINIC ACID RECEPTOR; PENICILLIN DERIVATIVE; PENTETRAZOLE; PENTOBARBITAL; PILOCARPINE; POTASSIUM ION; VERATRIDINE; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; CARRIER PROTEIN;

ACTION POTENTIAL; AMYGDALOID NUCLEUS; ANTICONVULSANT ACTIVITY; CALCIUM TRANSPORT; CHANNEL GATING; CHANNELOPATHY; CONVULSION; DENTATE GYRUS; ELECTRIC ACTIVITY; ELECTRIC SHOCK; ELECTROENCEPHALOGRAM; ELECTROSTIMULATION; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; EPILEPTOGENESIS; EXCITATORY POSTSYNAPTIC POTENTIAL; EXTRACELLULAR CALCIUM; FOCAL EPILEPSY; GENE EXPRESSION PROFILING; GENETIC MODEL; GRANULE CELL; HIGH FREQUENCY OSCILLATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HIPPOCAMPUS THETA RHYTHM; HUMAN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LIMBIC SYSTEM; MEMBRANE DEPOLARIZATION; MESIAL TEMPORAL LOBE EPILEPSY; MOTOR ACTIVITY; MYASTHENIA GRAVIS; NEOCORTEX; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PYRAMIDAL NERVE CELL; RECURRENT DISEASE; REM SLEEP; REPOLARIZATION; REVIEW; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; SEVERE MYOCLONIC EPILEPSY IN INFANCY; STIMULATION; TEMPORAL LOBE EPILEPSY; THETA RHYTHM; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; ELECTROPHYSIOLOGY; GENETICS; METABOLISM; PATHOPHYSIOLOGY; SEIZURE;

ANIMALIA;

ANIMALS; CHANNELOPATHIES; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; EPILEPSY, TEMPORAL LOBE; HUMANS; LIMBIC SYSTEM; MEMBRANE TRANSPORT PROTEINS; MODELS, NEUROLOGICAL; SEIZURES; STATUS EPILEPTICUS;

EID: 79955979850     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Review

References (326)

1. WT Blume, HO Luders, E Mizrahi, C Tassinari, W Van Emde Boas, Engel Jr. J.: Glossary of descriptive terminology for ictal semiology: Report of the ILAE task force on classification and terminology. Epilepsia 42, 1212-1218 (2001)
2. Engel Jr. J, A Berg, F Andermann, G Avanzini, S Berkovic, W Blume, O Dulac, W Van Emde Boas, N Fejerman, P Plouin, I Scheffer, M Seino, P Williamson, P Wolf: Are epilepsy classifications based on epileptic syndromes and seizure types outdated? Epileptic Disord 8, 159-160 (2006)
3. RS Fisher, W Van Emde Boas, W Blume, C Elger, P Genton, P Lee, Engel Jr. J.: Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46, 470-472 (2005)
4. Epilepsy ILA. RESEARCH PRIORITIES IN EPILEPSY FOR THE NEXT DECADE-A REPRESENTATIVE VIEW OF THE EUROPEAN SCIENTIFIC COMMUNITY. Summary of the ILAE Epilepsy Research Workshop, Brussels, 17-18 January 2008.
5. K Stavem, H Bjornaes, IA Langmoen: Predictors of seizure outcome after temporal lobectomy for intractable epilepsy. Acta Neurol Scand 109, 244-249 (2004)
6. R Surtees: Inherited ion channel disorders. Eur J Pediatr 159, S199-203 (2000)
7. RL Barchi: Ion channel mutations affecting muscle and brain. Curr Opin Neurol 11, 461-468 (1998)
8. K Staley, JL Hellier, FE Dudek: Do interictal spikes drive epileptogenesis? Neuroscientist 11, 272-276 (2005)
9. JS Ebersole, RA Levine: Abnormal neuronal responses during evolution of a penicillin epileptic focus in cat visual cortex. J Neurophysiol 38, 250-256 (1975)
10. GF Ayala: The paroxysmal depolarizing shift. Prog Clin Biol Res 124, 15-21 (1983)
11. NP Poolos: The h-Channel: A potential channelopathy in epilepsy? Epilepsy Behav 7, 51-56 (2005)
12. C Bernard, A Anderson, A Becker, NP Poolos, H Beck, D Johnston: Acquired dendritic channelopathy in temporal lobe epilepsy. Science 305, 532-535 (2004)
13. MP Jacobs, GG Leblanc, A Brooks-Kayal, FE Jensen, DH Lowenstein, JL Noebels, DD Spencer, JW Swann: Curing epilepsy: Progress and future directions. Epilepsy Behav 14, 438-445 (2009)
14. S Arroyo, MJ Brodie, G Avanzini, C Baumgartner, C Chiron, O Dulac, JA French, JM Serratosa: Is refractory epilepsy preventable? Epilepsia 43, 437-444 (2002)
15. F Semah, P Ryvlin: Can we predict refractory epilepsy at the time of diagnosis? Epileptic Disord 7, S10-13 (2005)
16. DT Depositario-Cabacar, JJ Riviello, M Takeoka: Present status of surgical intervention for children with intractable seizures. Curr Neurol Neurosci Rep 8, 123-129 (2008)
17. MJ Brodie: Diagnosing and predicting refractory epilepsy. Acta Neurol Scand Suppl 181, 36-39 (2005)
18. P Kwan, MJ Brodie: Early identification of refractory epilepsy. N Engl J Med 342, 314-319 (2000)
19. H Clusmann: Predictors, procedures, and perspective for temporal lobe epilepsy surgery. Semin Ultrasound CT MR 29, 60-70 (2008)
20. DW Kim, SK Lee, K Chu, KI Park, SY Lee, CH Lee, CK Chung, G Choe, JY Kim: Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia. Neurology 72, 211-216 (2009)
21. Engel Jr. J: Progress in epilepsy: Reducing the treatment gap and the promise of biomarkers. Curr Opin Neurol 21, 150-154 (2008)
22. I Savic, S Pauli, JO Thorell, G Blomqvist: In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. J Neurol Neurosurg Psychiatry 57, 797-804 (1994)
23. I Savic, L Widen, JO Thorell, G Blomqvist, K Ericson, P Roland: Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia 31, 724-730 (1990)
24. I Savic, A Persson, P Roland, S Pauli, G Sedvall, L Widen: In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2, 863-866 (1988)
25. AS Basile, BA Weissman, Skolnick P: Maximal electroshock increases the density of 3H)Ro 5-4864 binding to mouse cerebral cortex. Brain Res Bull 19, 1-7 (1987)
26. EF Berman, MW Adler: The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacology 23, 367-371 (1984)
27. LK Desmedt, CJ Niemegeers, PA Janssen: Anticonvulsive properties of cinnarizine and flunarizine in rats and mice. Arzneimittelforschung 25, 1408-1413 (1975)
28. W Loscher, CP Fassbender, B Nolting: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8, 79-94 (1991)
29. HS White, M Johnson, HH Wolf, HJ Kupferberg: The early identification of anticonvulsant activity: Role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital J Neurol Sci 16, 73-77 (1995)
30. GC Palmer, ML Stagnitto, JM Ordy, RC Griffith, JJ Napier, RJ Gentile, JH Woodhead, HS White, EA Swinyard: Preclinical profile of stereoisomers of the anticonvulsant remacemide in mice. Epilepsy Res 8, 36-48 (1991)
31. E Shek, T Murakami, C Nath, E Pop, NS Bodor: Improved anticonvulsant activity of phenytoin by a redox brain delivery system. III: Brain uptake and pharmacological effects. J Pharm Sci 78, 837-843 (1989)
32. JD Leander, DW Robertson, CR Clark, RR Lawson, RC Rathbun: Pharmacological effects of enantiomers of 4-Amino-N-(alpha-methylbenzyl) benzamide, a chemically novel anticonvulsant. Epilepsia 29, 83-90 (1988)
33. N Siddiqui, W Ahsan: Triazole incorporated thiazoles as a new class of anticonvulsants: Design, synthesis and in vivo screening. Eur J Med Chem 45, 1536-1543 (2010)
34. N Siddiqui, W Ahsan: Benzothiazole incorporated barbituric acid derivatives: Synthesis and anticonvulsant screening. Arch Pharm (Weinheim) 342, 462-468 (2009)
35. JJ Luszczki, KM Sawicka, J Kozinska, M Dudra-Jastrzebska, SJ Czuczwar: Amiloride enhances the anticonvulsant action of various antiepileptic drugs in the mouse maximal electroshock seizure model. J Neural Transm 116, 57-66 (2009)
36. A Talevi, CL Bellera, EA Castro, LE Bruno-Blanch: A successful virtual screening application: Prediction of anticonvulsant activity in MES test of widely used pharmaceutical and food preservatives methylparaben and propylparaben. J Comput Aided Mol Des 21, 527-538 (2007)
37. KK Borowicz, JJ Luszczki, G Sobieszek, N Ratnaraj, PN Patsalos, SJ Czuczwar: Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model. Eur Neuropsychopharmacol 17, 265-272 (2007)
38. W Fischer, H Kittner, R Regenthal, E Russo, G De Sarro: Effects of piracetam alone and in combination with antiepileptic drugs in rodent seizure models. J Neural Transm 111, 1121-1139 (2004)
39. W Loscher: Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50, 105-123 (2002)
40. GL Holmes, Q Zhao: Choosing the correct antiepileptic drugs: From animal studies to the clinic. Pediatr Neurol 38, 151-162 (2008)
41. EA Van Vliet, R Van Schaik, PM Edelbroek, FH da Silva, WJ Wadman, JA Gorter: Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia 49, 1151-1159 (2008)
42. H Beck: Plasticity of antiepileptic drug targets: Epilepsia 48, S14-18 (2007)
43. JE Pina-Garza, DR Nordli Jr, D Rating, H Yang, J Schiemann-Delgado, B Duncan: Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 50, 1141-1149 (2009)
44. J Peltola, C Coetzee, F Jimenez, T Litovchenko, S Ramaratnam, L Zaslavaskiy, ZS Lu, DM Sykes: Once-Daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: A doubleblind, randomized, placebo-Controlled trial. Epilepsia 50, 406-414 (2009)
45. S Li, J Cao, N Xiao, F Cai: Efficacy and Safety of Levetiracetam as an Add-On Therapy in Children Aged Less Than 4 Years With Refractory Epilepsy. J Child Neurol 25, 609-613 (2009)
46. DS Ledet, JW Wheless, JE Rubnitz, E Brannon Morris: Levetiracetam as monotherapy for seizures in a neonate with acute lymphoblastic leukemia. Eur J Paediatr Neurol 14, 78-79 (2010)
47. U Kramer, L Sagi, H Goldberg-Stern, N Zelnik, A Nissenkorn, B Ben-Zeev: Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 50, 1517-1524 (2009)
48. PC Giroux, M Salas-Prato, Y Theoret, L Carmant: Levetiracetam in children with refractory epilepsy: Lack of correlation between plasma concentration and efficacy. Seizure 18, 559-563 (2009)
49. S Berning, F Boesebeck, A Van Baalen, C Kellinghaus: Intravenous levetiracetam as treatment for status epilepticus. J Neurol 256, 1634-1642 (2009)
50. A Verrotti, C Cerminara, S Domizio, A Mohn, E Franzoni, G Coppola, N Zamponi, P Parisi, P Iannetti, P Curatolo: Levetiracetam in absence epilepsy. Dev Med Child Neurol 50, 850-853 (2008)
51. A Verrotti, C Cerminara, G Coppola, E Franzoni, P Parisi, P Iannetti, P Aloisi, E Tozzi, R Cusmai, F Vigevano, F Chiarelli, P Curatolo. Levetiracetam in juvenile myoclonic epilepsy: Long-term efficacy in newly diagnosed adolescents. Dev Med Child Neurol 50, 29-32 (2008)
52. DV Sharpe, AD Patel, B Abou-Khalil, GM Fenichel: Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure 17, 64-68 (2008)
53. RM Kaminski, A Matagne, K Leclercq, M Gillard, P Michel, B Kenda, P Talaga, H Klitgaard: SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 54, 715-720 (2008)
54. C Johannessen Landmark, SI Johannessen: Pharmacological management of epilepsy: Recent advances and future prospects. Drugs 68, 1925-1939 (2008)
55. JS Goraya, DS Khurana, I Valencia, JJ Melvin, M Cruz, A Legido, SV Kothare: Intravenous levetiracetam in children with epilepsy. Pediatr Neurol 38, 177-180 (2008)
56. A Gambardella, A Labate, E Colosimo, R Ambrosio, A Quattrone: Monotherapy for partial epilepsy: Focus on levetiracetam. Neuropsychiatr Dis Treat 4, 33-38 (2008)
57. H Klitgaard: Levetiracetam: The preclinical profile of a new class of antiepileptic drugs? Epilepsia 42, S13-S8 (2001)
58. CM Ulloa, A Towfigh, J Safdieh: Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. Neuropsychiatr Dis Treat 5, 467-476 (2009)
59. S Amano, N Ihara, S Uemura, M Yokoyama, M Ikeda, T Serikawa, M Sasahara, H Kataoka, Y Hayase, F Hazama: Development of a novel rat mutant with spontaneous limbic-like seizures. Am J Pathol 149, 329-336 (1996)
60. S Amano, N Ihara, S Uemura, M Yokoyama, M Ikeda, F Hazama: Neuropathological study on a newly developed epileptic rat mutant with limbic-like seizures. Psychiatry Clin Neurosci 49, S284-286 (1995)
61. GV Goddard, RM Douglas: Does the engram of kindling model the engram of normal long term memory? Can J Neurol Sci 2, 385-394 (1975)
62. N Cullen, GV Goddard: Kindling in the hypothalamus and transfer to the ipsilateral amygdala. Behav Biol 15, 119-131 (1975)
63. JA Wada: Kindling as a model of epilepsy: Electroencephalogr Clin Neurophysiol Suppl 34, 309-316 (1978)
64. JO McNamara, MC Byrne, RM Dasheiff, JG Fitz: The kindling model of epilepsy: A review. Prog Neurobiol 15, 139-159 (1980)
65. RG Perrin, HJ Hoffman: Temporal lobe epilepsy and kindling. Bol Estud Med Biol 30, 197-200 (1979)
66. K Morimoto, GV Goddard: Seizure-triggering mechanism in the kindling model of epilepsy: I. EEG changes during stimulation from the site of stimulation. Jpn J Psychiatry Neurol 42, 618-619 (1988)
67. E Maru, GV Goddard: Alteration in dentate neuronal activities associated with perforant path kindling. II. Decrease in granule cell excitability. Exp Neurol 96, 33-45 (1987)
68. K Morimoto, GV Goddard: Kindling induced changes in EEG recorded during stimulation from the site of stimulation: Collapse of GABA-mediated inhibition and onset of rhythmic synchronous burst. Exp Neurol 94, 571-584 (1986)
69. JC McEachern, CA Shaw: The plasticity-pathology continuum: Defining a role for the LTP phenomenon. J Neurosci Res 58, 42-61 (1999)
70. B Adams, M Lee, M Fahnestock, RJ Racine: Long-term potentiation trains induce mossy fiber sprouting. Brain Res 775, 193-197 (1997)
71. G Golarai, TP Sutula: Functional alterations in the dentate gyrus after induction of long-term potentiation, kindling, and mossy fiber sprouting. J Neurophysiol 75, 343-353 (1996)
72. LW Leung: Evaluation of the hypothesis that hippocampal interictal spikes are caused by long-term potentiation. Epilepsia 35, 785-794 (1994)
73. DP Cain: Long-term potentiation and kindling: Fow similar are the mechanisms? Trends Neurosci 12, 6-10 (1989)
74. DC McIntyre, KL Gilby: Kindling as a model of human epilepsy. Can J Neurol Sci 36, S33-35 (2009)
75. E Bertram: The relevance of kindling for human epilepsy. Epilepsia 48, 65-74 (2007)
76. ME Gilbert: Does the kindling model of epilepsy contribute to our understanding of multiple chemical sensitivity? Ann N Y Acad Sci 933, 68-91 (2001)
77. SK Kulkarni, B George: Kindling model of epilepsy. Methods Find Exp Clin Pharmacol 16, 735-745 (1994)
78. J Majkowski: Kindling: A model for epilepsy and memory. Acta Neurol Scand Suppl 109, 97-108 (1986)
79. JO McNamara: Kindling model of epilepsy. Adv Neurol 44, 303-318 (1986)
80. JO McNamara, DW Bonhaus, C Shin, BJ Crain, RL Gellman, JL Giacchino: The kindling model of epilepsy: A critical review. CRC Crit Rev Clin Neurobiol 1, 341-391 (1985)
81. JO McNamara: Kindling: An animal model of complex partial epilepsy. Ann Neurol 16, S72-76 (1984)
82. J Tuunanen, T Halonen, A Pitkanen: Decrease in somatostatin- immunoreactive neurons in the rat amygdaloid complex in a kindling model of temporal lobe epilepsy. Epilepsy Res 26, 315-327 (1997)
83. TP Sutula, JE Cavazos, AR Woodard: Long-term structural and functional alterations induced in the hippocampus by kindling: Implications for memory dysfunction and the development of epilepsy. Hippocampus 4, 254-258 (1994)
84. TP Sutula: Reactive changes in epilepsy: Cell death and axon sprouting induced by kindling. Epilepsy Res 10, 62-70 (1991)
85. TP Sutula: Experimental models of temporal lobe epilepsy: New insights from the study of kindling and synaptic reorganization. Epilepsia 31, S45-54 (1990)
86. DA Rempe, PS Mangan, EW Lothman: Regional heterogeneity of pathophysiological alterations in CA1 and dentate gyrus in a chronic model of temporal lobe epilepsy. J Neurophysiol 74, 816-828 (1995)
87. PS Mangan, DA Rempe, EW Lothman: Changes in inhibitory neurotransmission in the CA1 region and dentate gyrus in a chronic model of temporal lobe epilepsy. J Neurophysiol 74, 829-840 (1995)
88. EW Lothman, DA Rempe, PS Mangan: Changes in excitatory neurotransmission in the CA1 region and dentate gyrus in a chronic model of temporal lobe epilepsy. J Neurophysiol 74, 841-848 (1995)
89. EW Lothman, EH Bertram, J Kapur, JL Stringer: Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res 6, 110-118 (1990)
90. EW Lothman, EH Bertram, JW Bekenstein, JB Perlin: Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: Electrographic and behavioral characteristics. Epilepsy Res 3, 107-119 (1989)
91. J Nissinen, T Halonen, E Koivisto, A Pitkanen: A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat. Epilepsy Res 38, 177-205 (2000)
92. A Pitkanen, J Nissinen, K Lukasiuk, L Jutila, L Paljarvi, T Salmenpera, K Karkola, M Vapalahti, A Ylinen: Association between the density of mossy fiber sprouting and seizure frequency in experimental and human temporal lobe epilepsy. Epilepsia 41, S24-29 (2000)
93. C Brandt, M Glien, H Potschka, H Volk, W Loscher: Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats. Epilepsy Res 55, 83-103 (2003)
94. JL Stringer, JM Williamson, EW Lothman: Induction of paroxysmal discharges in the dentate gyrus: Frequency dependence and relationship to afterdischarge production. J Neurophysiol 62, 126-135 (1989)
95. JW Olney, V Rhee, OL Ho: Kainic acid: A powerful neurotoxic analogue of glutamate. Brain Res 77, 507-512 (1974)
96. R Zaczek, M Nelson, JT Coyle: Kainic acid neurotoxicity and seizures. Neuropharmacology 20, 183-189 (1981)
97. Y Ben-Ari, E Tremblay, D Riche, G Ghilini, R Naquet: Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6, 1361-1391 (1981)
98. JV Nadler, BW Perry, CW Cotman: Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 271, 676-677 (1978)
99. Y Ben-Ari, J Lagowska, E Tremblay, G Le Gal La Salle: A new model of focal status epilepticus: Intraamygdaloid application of kainic acid elicits repetitive secondarily generalized convulsive seizures. Brain Res 163, 176-179 (1979)
100. Y Ben-Ari, E Tremblay, OP Ottersen: Injections of kainic acid into the amygdaloid complex of the rat: An electrographic, clinical and histological study in relation to the pathology of epilepsy. Neuroscience 5, 515-528 (1980)
101. MF Nelson, R Zaczek, JT Coyle: Effects of sustained seizures produced by intrahippocampal injection of kainic acid on noradrenergic neurons: Evidence for local control of norepinephrine release. J Pharmacol Exp Ther 214, 694-702 (1980)
102. C Menini, BS Meldrum, D Riche, C Silva-Comte, JM Stutzmann: Sustained limbic seizures induced by intraamygdaloid kainic acid in the baboon: Symptomatology and neuropathological consequences. Ann Neurol 8, 501-509 (1980)
103. T Tanaka, M Kaijima, G Daita, S Ohgami, Y Yonemasu, D Riche: Electroclinical features of kainic acidinduced status epilepticus in freely moving cats. Microinjection into the dorsal hippocampus. Electroencephalogr Clin Neurophysiol 54, 288-300 (1982)
104. Y Ben-Ari, E Tremblay, OP Ottersen, BS Meldrum: The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res 191, 79-97 (1980)
105. M Pisa, PR Sanberg, ME Corcoran, HC Fibiger: Spontaneously recurrent seizures after intracerebral injections of kainic acid in rat: A possible model of human temporal lobe epilepsy. Brain Res 200, 481-487 (1980)
106. JV Nadler: Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 29, 2031-2042 (1981)
107. EW Lothman, RC Collins, JA Ferrendelli: Kainic acid-induced limbic seizures: Electrophysiologic studies. Neurology 31, 806-812 (1981)
108. EW Lothman, RC Collins: Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 218, 299-318 (1981)
109. TJ Ashwood, B Lancaster, HV Wheal: Intracellular electrophysiology of CA1 pyramidal neurones in slices of the kainic acid lesioned hippocampus of the rat. Exp Brain Res 62, 189-198 (1986)
110. S Nakajima, JE Franck, D Bilkey, PA Schwartzkroin: Local circuit synaptic interactions between CA1 pyramidal cells and interneurons in the kainate-lesioned hyperexcitable hippocampus. Hippocampus 1, 67-78 (1991)
111. EA Cavalheiro, DA Riche, G Le Gal La Salle: Longterm effects of intrahippocampal kainic acid injection in rats: A method for inducing spontaneous recurrent seizures. Electroencephalogr Clin Neurophysiol 53, 581-589 (1982)
112. RS Sloviter, BP Damiano: On the relationship between kainic acid-induced epileptiform activity and hippocampal neuronal damage. Neuropharmacology 20, 1003-1011 (1981)
113. R Naquet, B Meldrum, Y Ben-Ari: Fippocampal lesions and status epilepticus. Electroencephalogr Clin Neurophysiol Suppl 35, 171-183 (1982)
114. Y Ben-Ari, A Represa, E Tremblay, O Robain, G Le Gal La Salle, C Rovira, M Gho, E Cherubini: Epileptogenesis and neuronal plasticity: Studies on kainate receptor in the human and rat hippocampus. Epilepsy Res Suppl 8, 369-373 (1992)
115. LD Cahan, JW Geddes, BH Choi, C Cotman: Excitotoxic amino acid receptors in human complex partial epilepsy. Stereotact Funct Neurosurg 54-55, 21-24 (1990)
116. AC Foster: Involvement of excitatory amino acid receptors in the mechanisms underlying excitotoxic phenomena. Adv Exp Med Biol 203, 303-316 (1986)
117. JT Coyle, R Zaczek, J Slevin, J Collins: Neuronal receptor sites for kainic acid: Correlations with neurotoxicity. Adv Biochem Psychopharmacol 27, 337-346 (1981)
118. WA Turski, EA Cavalheiro, M Schwarz, SJ Czuczwar, Z Kleinrok, L Turski: Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study. Behav Brain Res 9, 315-335 (1983)
119. DB Clifford, JW Olney, A Maniotis, RC Collins, CF Zorumski: The functional anatomy and pathology of lithium-pilocarpine and high-Dose pilocarpine seizures. Neuroscience 23, 953-968 (1987)
120. Z Liu, T Nagao, GC Desjardins, P Gloor, M Avoli: Quantitative evaluation of neuronal loss in the dorsal hippocampus in rats with long-term pilocarpine seizures. Epilepsy Res 17, 237-247 (1994)
121. LM Tetz, PE Rezk, RH Ratcliffe, RK Gordon, KE Steele, MP Nambiar: Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure. Toxicol Ind Health 22, 255-266 (2006)
122. RA Morrisett, RS Jope, OC Snead 3rd: Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: Comparison with kainic acid. Exp Neurol 98, 594-605 (1987)
123. RA Morrisett, RS Jope, OC Snead 3rd: Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithiumpretreated rats. Exp Neurol 97, 193-200 (1987)
124. V Andre, A Ferrandon, C Marescaux, A Nehlig: The lesional and epileptogenic consequences of lithiumpilocarpine-induced status epilepticus are affected by previous exposure to isolated seizures: Effects of amygdala kindling and maximal electroshocks. Neuroscience 99, 469-481 (2000)
125. B Noyan, G Gulec: Effects of L-Arginine on prevention and treatment of lithium-pilocarpine-induced status epilepticus. Physiol Res 49, 379-385 (2000)
126. V Andre, A Ferrandon, C Marescaux, A Nehlig: Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 47, 99-117 (2001)
127. V Andre, C Marescaux, A Nehlig, JM Fritschy: Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 11, 452-468 (2001)
128. DW Cadotte, B Xu, RJ Racine, GM MacQueen, JF Wang, B McEwen, LT Young: Chronic lithium treatment inhibits pilocarpine-induced mossy fiber sprouting in rat hippocampus. Neuropsychopharmacology 28, 1448-1453 (2003)
129. MA Persinger, MJ Dupont: Emergence of spontaneous seizures during the year following lithium/pilocarpine-induced epilepsy and neuronal loss within the right temporal cortices. Epilepsy Behav 5, 440-445 (2004)
130. MA Rigoulot, E Koning, A Ferrandon, A Nehlig: Neuroprotective properties of topiramate in the lithiumpilocarpine model of epilepsy. J Pharmacol Exp Ther 308, 787-795 (2004)
131. V Andre, C Dube, J Francois, C Leroy, MA Rigoulot, C Roch, IJ Namer, A Nehlig: Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model. Epilepsia 48, S41-47 (2007)
132. RS Jope, RA Morrisett, OC Snead: Characterization of lithium potentiation of pilocarpineinduced status epilepticus in rats. Exp Neurol 91, 471-480 (1986)
133. CJ Muller, M Bankstahl, I Groticke, W Loscher: Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: Development of spontaneous seizures, behavioral alterations and neuronal damage. Eur J Pharmacol 619, 15-24 (2009)
134. I Groticke, K Hoffmann, W Loscher: Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate. Exp Neurol 213, 71-83 (2008)
135. Mde A Furtado, GK Braga, JA Oliveira, F Del Vecchio, N Garcia-Cairasco: Behavioral, morphologic, and electroencephalographic evaluation of seizures induced by intrahippocampal microinjection of pilocarpine. Epilepsia 43, S37-39 (2002)
136. FA Scorza, RM Arida, Mda G Naffah-Mazzacoratti, DA Scerni, L Calderazzo, EA Cavalheiro: The pilocarpine model of epilepsy: What have we learned? An Acad Bras Cienc 81, 345-365 (2009)
137. EA Cavalheiro: The pilocarpine model of epilepsy. Ital J Neurol Sci 16, 33-37 (1995)
138. ER Garrido-Sanabria, LF Otalora, MF Arshadmansab, B Herrera, S Francisco, BS Ermolinsky: Impaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats. Brain Res 1240, 165-176 (2008)
139. B Ermolinsky, MF Arshadmansab, LF Pacheco Otalora, MM Zarei, ER Garrido-Sanabria: Deficit of Kcnma1 mRNA expression in the dentate gyrus of epileptic rats. Neuroreport 19, 1291-1294 (2008)
140. ER Garrido Sanabria, MT Castaneda, C Banuelos, MG Perez-Cordova, S Hernandez, LV Colom: Septal GABAergic neurons are selectively vulnerable to pilocarpine-induced status epilepticus and chronic spontaneous seizures. Neuroscience 142, 871-883 (2006)
141. LF Pacheco Otalora, J Couoh, R Shigamoto, MM Zarei, ER Garrido Sanabria: Abnormal mGluR2/3 expression in the perforant path termination zones and mossy fibers of chronically epileptic rats. Brain Res 1098, 170-185 (2006)
142. T Lemos, EA Cavalheiro: Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp Brain Res 102, 423-428 (1995)
143. G Biagini, E Baldelli, D Longo, L Pradelli, I Zini, MA Rogawski, M Avoli: Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol 201, 519-524 (2006)
144. K Goffin, J Nissinen, K Van Laere, A Pitkanen: Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat. Exp Neurol 205, 501-505 (2007)
145. WA Turski, EA Cavalheiro, ZA Bortolotto, LM Mello, M Schwarz, L Turski: Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysis. Brain Res 321, 237-253 (1984)
146. JP Leite, ZA Bortolotto, EA Cavalheiro: Spontaneous recurrent seizures in rats: An experimental model of partial epilepsy. Neurosci Biobehav Rev 14, 511-517 (1990)
147. NY Walton, DM Treiman: Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Res 553, 97-104 (1991)
148. EA Cavalheiro, JP Leite, ZA Bortolotto, WA Turski, C Ikonomidou, L Turski: Long-term effects of pilocarpine in rats: Structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32, 778-782 (1991)
149. RM Arida, FA Scorza, CA Peres, EA Cavalheiro: The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Res 34, 99-107 (1999)
150. ER Sanabria, H Su, Y Yaari: Initiation of network bursts by Ca2+-Dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy. J Physiol 532, 205-216 (2001)
151. FE Dudek, TP Sutula: Epileptogenesis in the dentate gyrus: A critical perspective. Prog Brain Res 163, 755-773 (2007)
152. HE Scharfman: The neurobiology of epilepsy. Curr Neurol Neurosci Rep 7, 348-354 (2007)
153. Engel Jr. J: Mesial temporal lobe epilepsy: What have we learned? Neuroscientist 7, 340-352 (2001)
154. M Bikson, JE Fox, JG Jefferys: Neuronal aggregate formation underlies spatiotemporal dynamics of nonsynaptic seizure initiation. J Neurophysiol 89, 2330-2333 (2003)
155. GT Finnerty, JG Jefferys: Investigation of the neuronal aggregate generating seizures in the rat tetanus toxin model of epilepsy. J Neurophysiol 88, 2919-2927 (2002)
156. JS Ebersole, AB Chatt: Toward a unified theory of focal penicillin epileptogenesis: An intracortical evoked potential investigation. Epilepsia 22, 347-363 (1981)
157. M Dichter, WA Spencer: Fippocampal penicillin "spike" discharge: Epileptic neuron or epileptic aggregate? Neurology 18, 282-283 (1968)
158. CC Young, M Stegen, R Bernard, M Muller, J Bischofberger, RW Veh, CA Haas, J Wolfart: Upregulation of inward rectifier K+ (Kir2) channels in dentate gyrus granule cells in temporal lobe epilepsy. J Physiol 587, 4213-4233 (2009)
159. M Stegen, CC Young, CA Haas, J Zentner, J Wolfart: Increased leak conductance in dentate gyrus granule cells of temporal lobe epilepsy patients with Ammon's horn sclerosis. Epilepsia 50, 646-653 (2009)
160. RS Winokur, T Kubal, D Liu, SF Davis, BN Smith: Recurrent excitation in the dentate gyrus of a murine model of temporal lobe epilepsy. Epilepsy Res 58, 93-105 (2004)
161. RS Sloviter: Possible functional consequences of synaptic reorganization in the dentate gyrus of kainatetreated rats. Neurosci Lett 137, 91-96 (1992)
162. MM Okazaki, P Molnar, JV Nadler: Recurrent mossy fiber pathway in rat dentate gyrus: Synaptic currents evoked in presence and absence of seizure-induced growth. J Neurophysiol 81, 1645-1660 (1999)
163. LE Mello, EA Cavalheiro, AM Tan, WR Kupfer, JK Pretorius, TL Babb, DM Finch: Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: Cell loss and mossy fiber sprouting. Epilepsia 34, 985-995 (1993)
164. JE Austin, PS Buckmaster: Recurrent excitation of granule cells with basal dendrites and low interneuron density and inhibitory postsynaptic current frequency in the dentate gyrus of macaque monkeys. J Comp Neurol 476, 205-218 (2004)
165. M Kobayashi, PS Buckmaster: Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23, 2440-2452 (2003)
166. PS Buckmaster, GF Zhang, R Yamawaki: Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit. J Neurosci 22, 6650-6658 (2002)
167. P Perreault, M Avoli: Physiology and pharmacology of epileptiform activity induced by 4-Aminopyridine in rat hippocampal slices. J Neurophysiol 65, 771-785 (1991)
168. OV Godukhin, SG Levin, EY Parnyshkova: The effects of interleukin-10 on the development of epileptiform activity in the hippocampus induced by transient hypoxia, bicuculline, and electrical kindling. Neurosci Behav Physiol 39, 625-631 (2009)
169. RA Voskuyl, H Albus: Spontaneous epileptiform discharges in hippocampal slices induced by 4-Aminopyridine. Brain Res 342, 54-66 (1985)
170. T Nagao, A Alonso, M Avoli: Epileptiform activity induced by pilocarpine in the rat hippocampal-entorhinal slice preparation. Neuroscience 72, 399-408 (1996)
171. MS Jensen, Y Yaari: Role of intrinsic burst firing, potassium accumulation, and electrical coupling in the elevated potassium model of hippocampal epilepsy. J Neurophysiol 77, 1224-1233 (1997)
172. MS Jensen, R Azouz, Y Yaari: Variant firing patterns in rat hippocampal pyramidal cells modulated by extracellular potassium. J Neurophysiol 71, 831-839 (1994)
173. MS Jensen, E Cherubini, Y Yaari: Opponent effects of potassium on GABAA-mediated postsynaptic inhibition in the rat hippocampus. J Neurophysiol 69, 764-771 (1993)
174. Y Yaari, A Konnerth, U Heinemann: Nonsynaptic epileptogenesis in the mammalian hippocampus in vitro. II. Role of extracellular potassium. J Neurophysiol 56, 424-438 (1986)
175. EJ Furshpan, DD Potter: Seizure-like activity and cellular damage in rat hippocampal neurons in cell culture. Neuron 3, 199-207 (1989)
176. I Mody, JD Lambert, U Heinemann: Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 57, 869-888 (1987)
177. JH Schneiderman, JF MacDonald: Effects of reduced magnesium on hippocampal synchrony. Brain Res 410, 174-178 (1987)
178. ML Mayer, GL Westbrook, PB Guthrie: Voltagedependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 309, 261-263 (1984)
179. L Nowak, P Bregestovski, P Ascher, A Herbet, A Prochiantz: Magnesium gates glutamate-Activated channels in mouse central neurones. Nature 307, 462-465 (1984)
180. C Psarropoulou, HL Haas: Action of anticonvulsants on hippocampal slices in Mg-Free medium. Naunyn Schmiedebergs Arch Pharmacol 339, 613-616 (1989)
181. AJ Hill, NA Jones, CM Williams, GJ Stephens, BJ Whalley: Development of multi-electrode array screening for anticonvulsants in acute rat brain slices. J Neurosci Methods 185, 246-256 (2010)
182. RS Fisher: Animal models of the epilepsies. Brain Res Brain Res Rev 14, 245-278 (1989)
183. S Birnstiel, E Wulfert, SG Beck: Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 356, 611-618 (1997)
184. GJ Klapstein, WF Colmers: Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol 78, 1651-1661 (1997)
185. B Ault, CM Wang: Adenosine inhibits epileptiform activity arising in hippocampal area CA3. Br J Pharmacol 87, 695-703 (1986)
186. AL Mueller, TV Dunwiddie: Anticonvulsant and proconvulsant actions of alpha-And beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro. Epilepsia 24, 57-64 (1983)
187. AP Oliver, BJ Hoffer, RJ Wyatt: The hippocampal slice: A system for studying the pharmacology of seizures and for screening anticonvulsant drugs. Epilepsia 18, 543-548 (1977)
188. F Lehmann-Horn, K Jurkat-Rott: Voltage-Gated ion channels and hereditary disease. Physiol Rev 79, 1317-1372 (1999)
189. RS Kass: The channelopathies: Novel insights into molecular and genetic mechanisms of human disease. J Clin Invest 115, 1986-1989 (2005)
190. FM Ashcroft: ATP-sensitive potassium channelopathies: Focus on insulin secretion. J Clin Invest 115, 2047-2058 (2005)
191. B Lang, A Vincent: Autoantibodies to ion channels at the neuromuscular junction. Autoimmun Rev 2, 94-100 (2003)
192. OK Steinlein: Genetic mechanisms that underlie epilepsy. Nat Rev Neurosci 5, 400-408 (2004)
193. NA Singh, P Westenskow, C Charlier, C Pappas, J Leslie, J Dillon, VE Anderson, MC Sanguinetti, MF Leppert: KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: Expansion of the functional and mutation spectrum. Brain 126, 2726-2737 (2003)
194. SE Heron, HA Phillips, JC Mulley, A Mazarib, MY Neufeld, SF Berkovic, IE Scheffer: Genetic variation of CACNA1H in idiopathic generalized epilepsy. Ann Neurol 55, 595-596 (2004)
195. J Spampanato, A Escayg, MH Meisler, AL Goldin: Functional effects of two voltage-Gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J Neurosci 21, 7481-7490 (2001)
196. A Gambardella, A Labate, A Giallonardo, U Aguglia: Familial mesial temporal lobe epilepsies: Clinical and genetic features. Epilepsia 50, S55-57 (2009)
197. A Gambardella, C Marini: Clinical spectrum of SCN1A mutations. Epilepsia 50, S20-23 (2009)
198. MH Meisler, JA Kearney: Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 115, 2010-2017 (2005)
199. S Jung, TD Jones, JN Lugo Jr, AH Sheerin, JW Miller, R D'Ambrosio, AE Anderson, NP Poolos: Progressive dendritic HCN channelopathy during epileptogenesis in the rat pilocarpine model of epilepsy. J Neurosci 27, 13012-13021 (2007)
200. RK Ellerkmann, S Remy, J Chen, D Sochivko, CE Elger, BW Urban, A Becker, H Beck: Molecular and functional changes in voltage-Dependent Na (+) channels following pilocarpine-induced status epilepticus in rat dentate granule cells. Neuroscience 119, 323-333 (2003)
201. AR Brooks-Kayal, MD Shumate, H Jin, TY Rikhter, DA Coulter: Selective changes in single cell GABA (A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4, 1166-1172 (1998)
202. JD Graef, BK Nordskog, WF Wiggins, DW Godwin: An acquired channelopathy involving thalamic T-type Ca2+ channels after status epilepticus. J Neurosci 29, 4430-4441 (2009)
203. G Avanzini, S Franceschetti, M Mantegazza: Epileptogenic channelopathies: Experimental models of human pathologies. Epilepsia 48, S51-64 (2007)
204. B Marcelin, L Chauviere, A Becker, M Migliore, M Esclapez, C Bernard: F channel-Dependent deficit of theta oscillation resonance and phase shift in temporal lobe epilepsy. Neurobiol Dis 33, 436-447 (2009)
205. Jr. Naegele: Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy. Epilepsia 48, S107-117 (2007)
206. T Deller, CA Haas, TM Freiman, A Phinney, M Jucker, M Frotscher: Lesion-induced axonal sprouting in the central nervous system. Adv Exp Med Biol 557, 101-121 (2006)
207. JM Parent, DH Lowenstein: Seizure-induced neurogenesis: Are more new neurons good for an adult brain? Prog Brain Res 135, 121-131 (2002)
208. JM Parent, TW Yu, RT Leibowitz, DH Geschwind, RS Sloviter, DH Lowenstein: Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 17, 3727-3738 (1997)
209. CR Houser: Morphological changes in the dentate gyrus in human temporal lobe epilepsy. Epilepsy Res Suppl 7, 223-234 (1992)
210. JW Geddes, MC Wilson, FD Miller, CW Cotman: Molecular markers of reactive plasticity. Adv Exp Med Biol 268, 425-432 (1990)
211. JE Cavazos, DJ Cross: The role of synaptic reorganization in mesial temporal lobe epilepsy. Epilepsy Behav 8, 483-493 (2006)
212. EW Lothman, EH Bertram 3rd: Epileptogenic effects of status epilepticus. Epilepsia 34, S59-70 (1993)
213. AB Scheibel: Morphological correlates of epilepsy: Cells in the hippocampus. Adv Neurol 27, 49-61 (1980)
214. JE Kralic, DA Ledergerber, JM Fritschy: Disruption of the neurogenic potential of the dentate gyrus in a mouse model of temporal lobe epilepsy with focal seizures. Eur J Neurosci 22, 1916-1927 (2005)
215. T Miyazaki, O Miyamoto, NA Janjua, T Hata, F Takahashi, T Itano: Reactive gliosis in areas around third ventricle in association with epileptogenesis in amygdaloidkindled rat. Epilepsy Res 56, 5-15 (2003)
216. HK Wolf, AF Aliashkevich, I Blumcke, OD Wiestler, J Zentner: Neuronal loss and gliosis of the amygdaloid nucleus in temporal lobe epilepsy. A quantitative analysis of 70 surgical specimens. Acta Neuropathol 93, 606-610 (1997)
217. G Seifert, G Carmignoto, C Steinhauser: Astrocyte dysfunction in epilepsy. Brain Res Rev 63, 212-221 (2010)
218. A Pitkanen, K Lukasiuk: Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 14, S16-25 (2009)
219. R Jabs, G Seifert, C Steinhauser: Astrocytic function and its alteration in the epileptic brain. Epilepsia 49, S3-12 (2008)
220. DK Binder, C Steinhauser: Functional changes in astroglial cells in epilepsy. Glia 54, 358-368 (2006)
221. C Kendal, I Everall, C Polkey, S Al-Sarraj: Glial cell changes in the white matter in temporal lobe epilepsy. Epilepsy Res 36, 43-51 (1999)
222. SA Baxendale, W Van Paesschen, PJ Thompson, JS Duncan, WF Harkness, SD Shorvon: Fippocampal cell loss and gliosis: Relationship to preoperative and postoperative memory function. Neuropsychiatry Neuropsychol Behav Neurol 11, 12-21 (1998)
223. DV Lewis: Losing neurons: Selective vulnerability and mesial temporal sclerosis. Epilepsia 46, S39-44 (2005)
224. S Waldbaum, M Patel: Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 88, 23-45 (2010)
225. S Xu, Q Pang, Y Liu, W Shang, G Zhai, M Ge: Neuronal apoptosis in the resected sclerotic hippocampus in patients with mesial temporal lobe epilepsy. J Clin Neurosci 14, 835-840 (2007)
226. DG Fujikawa: Neuronal death in mesial temporal sclerosis: Separating morphology from mechanism. Epilepsia 44, 1607 (2003)
227. H Uysal, IU Cevik, F Soylemezoglu, B Elibol, YG Ozdemir, T Evrenkaya, S Saygi, T Dalkara: Is the cell death in mesial temporal sclerosis apoptotic? Epilepsia 44, 778-784 (2003)
228. J Choi, DR Nordli Jr, TD Alden, A DiPatri Jr, L Laux, K Kelley, J Rosenow, SU Schuele, V Rajaram, S Koh: Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 6, 38 (2009).
229. L Bernardino, R Ferreira, AJ Cristovao, F Sales, JO Malva: Inflammation and neurogenesis in temporal lobe epilepsy. Curr Drug Targets CNS Neurol Disord 4, 349-360 (2005)
230. DM Kullmann: The neuronal channelopathies. Brain 125, 1177-1195 (2002)
231. LJ Ptacek, YH Fu: Channelopathies: Episodic disorders of the nervous system. Epilepsia 42, S35-43 (2001)
232. H Lerche, K Jurkat-Rott, F Lehmann-Horn: Ion channels and epilepsy. Am J Med Genet 106, 146-159 (2001)
233. M Li, HA Lester: Ion channel diseases of the central nervous system. CNS Drug Rev 7, 214-240 (2001)
234. EF Bond: Channelopathies: Potassium-related periodic paralyses and similar disorders. AACN Clin Issues 11, 261-270 (2000)
235. GG Celesia: Disorders of membrane channels or channelopathies. Clin Neurophysiol 112, 2-18 (2001)
236. MA Rogawski: KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: Implications for therapy. Trends Neurosci 23, 393-398 (2000)
237. OK Steinlein, JL Noebels: Ion channels and epilepsy in man and mouse. Curr Opin Genet Dev 10, 286-291 (2000)
238. YY Wang, P Smith, M Murphy, M Cook: Global Expression Profiling in Epileptogenesis: Does It Add to the Confusion? Brain Pathol 20, 1-16 (2010)
239. MH Meisler, J Kearney, R Ottman, A Escayg: Identification of epilepsy genes in human and mouse. Annu Rev Genet 35, 567-588 (2001)
240. BS Meldrum, MA Rogawski: Molecular targets for antiepileptic drug development. Neurotherapeutics 4, 18-61 (2007)
241. MA Rogawski, W Loscher: The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5, 553-564 (2004)
242. GA Gutman, KG Chandy, S Grissmer, M Lazdunski, D McKinnon, LA Pardo, GA Robertson, B Rudy, MC Sanguinetti, W Stuhmer, X Wang: International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-Gated potassium channels. Pharmacol Rev 57, 473-508 (2005)
243. SA Goldstein, DA Bayliss, D Kim, F Lesage, LD Plant, S Rajan. International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 57, 527-540 (2005)
244. Y Kubo, JP Adelman, DE Clapham, LY Jan, A Karschin, Y Kurachi, M Lazdunski, CG Nichols, S Seino, CA Vandenberg: International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 57, 509-526 (2005)
245. AD Wei, GA Gutman, R Aldrich, KG Chandy, S Grissmer, H Wulff: International Union of Pharmacology. LII. Nomenclature and molecular relationships of calciumactivated potassium channels. Pharmacol Rev 57, 463-472 (2005)
246. A Mathie, Jr. Wooltorton, CS Watkins: Voltageactivated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol 30, 13-24 (1998)
247. MJ Christie: Molecular and functional diversity of K+ channels. Clin Exp Pharmacol Physiol 22, 944-951 (1995)
248. O Pongs: Regulation of excitability by potassium channels. Results Probl Cell Differ 44, 145-161 (2008)
249. L Feinshreiber, D Singer-Lahat, U Ashery, I Lotan: Voltage-Gated potassium channel as a facilitator of exocytosis. Ann N Y Acad Sci 1152, 87-92 (2009)
250. G Edwards, AH Weston: The role of potassium channels in excitable cells. Diabetes Res Clin Pract 28, S57-66 (1995)
251. MM Monaghan, M Menegola, H Vacher, KJ Rhodes, JS Trimmer: Altered expression and localization of hippocampal A-type potassium channel subunits in the pilocarpine-induced model of temporal lobe epilepsy. Neuroscience 156, 550-562 (2008)
252. T Su, WD Cong, YS Long, AH Luo, WW Sun, WY Deng, WP Liao: Altered expression of voltage-Gated potassium channel 4.2 and voltage-Gated potassium channel 4-interacting protein, and changes in intracellular calcium levels following lithium-pilocarpine-induced status epilepticus. Neuroscience 157, 566-576 (2008)
253. SM Lee, JE Kim, JH Sohn, HC Choi, JS Lee, SH Kim, MJ Kim, IG Choi, TC Kang: Down-regulation of delayed rectifier K (+) channels in the hippocampus of seizure sensitive gerbils. Brain Res Bull 80, 433-442 (2009)
254. LL Yuan, JP Adams, M Swank, JD Sweatt, D Johnston: Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-Activated protein kinase pathway. J Neurosci 22, 4860-4868 (2002)
255. B Singh, I Ogiwara, M Kaneda, N Tokonami, E Mazaki, K Baba, K Matsuda, Y Inoue, K Yamakawa: A Kv4.2 truncation mutation in a patient with temporal lobe epilepsy. Neurobiol Dis 24, 245-253 (2006)
256. E Yus-Najera, A Munoz, N Salvador, BS Jensen, HB Rasmussen, J Defelipe, A Villarroel: Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation. Neuroscience 120, 353-364 (2003)
257. JJ Lawrence, F Saraga, JF Churchill, JM Statland, KE Travis, FK Skinner, CJ McBain: Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons. J Neurosci 26, 12325-12338 (2006)
258. JJ Luszczki. Third-Generation antiepileptic drugs: Mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep 61, 197-216 (2009)
259. L Tatulian, P Delmas, FC Abogadie, DA Brown: Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anticonvulsant drug retigabine. J Neurosci 21, 5535-5545 (2001)
260. MC Walker, JW Sander: New anti-epileptic drugs. Expert Opin Investig Drugs 8, 1497-1510 (1999)
261. ES Faber: Functions and modulation of neuronal SK channels. Cell Biochem Biophys 55, 127-139 (2009)
262. ES Faber, P Sah: Functions of SK channels in central neurons. Clin Exp Pharmacol Physiol 34, 1077-1083 (2007)
263. P Pedarzani, M Stocker: Molecular and cellular basis of small-And intermediate-Conductance, calcium-Activated potassium channel function in the brain. Cell Mol Life Sci 65, 3196-3217 (2008)
264. VK Gribkoff, JE Starrett Jr, SI Dworetzky: Maxi-K potassium channels: Form, function, and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist 7, 166-177 (2001)
265. P Sah, P Davies: Calcium-Activated potassium currents in mammalian neurons. Clin Exp Pharmacol Physiol 27, 657-663 (2000)
266. W Du, JF Bautista, H Yang, A Diez-Sampedro, SA You, L Wang, P Kotagal, HO Luders, J Shi, J Cui, GB Richerson, QK Wang: Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet 37, 733-738 (2005)
267. R Brenner, QH Chen, A Vilaythong, GM Toney, JL Noebels, RW Aldrich: BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci 8, 1752-1759 (2005)
268. LF Pacheco Otalora, EF Hernandez, MF Arshadmansab, S Francisco, M Willis, B Ermolinsky, M Zarei, HG Knaus, ER Garrido-Sanabria: Downregulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy. Brain Res 1200, 116-131 (2008)
269. MS Oliveira, F Skinner, MF Arshadmansab, I Garcia, CF Mello, HG Knaus, BS Ermolinsky, LF Otalora, ER Garrido-Sanabria: Altered expression and function of small-Conductance (SK) Ca (2+)-Activated K+ channels in pilocarpine-treated epileptic rats. Brain Res 1348, 187-199 (2010)
270. X-Y Wu, Z Hong, X Gao, G-X Zhu, C-Z Lü: Alterations in KCNJ4 gene expression in human temporal lobe epilepsy. Chin J Neurol 39, 242-245 (2006)
271. L Xu, X-Y Wu, Z Hong: Dynamic changes of Kir2. 3 mRNA in the hippocampus of rats with chronic temporal lobe epilepsy. Fudan University J Med Sci 36, 427-430 (2009)
272. JE Kim, SE Kwak, SY Choi, TC Kang: Regionspecific alterations in astroglial TWIK-related acidsensitive K+-1 channel immunoreactivity in the rat hippocampal complex following pilocarpine-induced status epilepticus. J Comp Neurol 510, 463-474 (2008)
273. JE Kim, SE Kwak, TC Kang: Upregulated TWIKrelated acid-sensitive K+ channel-2 in neurons and perivascular astrocytes in the hippocampus of experimental temporal lobe epilepsy. Epilepsia 50, 654-663 (2009)
274. Y Wang, B Xiao, X-S Yang, X-Y Long, S-Y Li, G-L Li, J-H Liang: Altered expression of G protein-Coupled inwardly rectifier potassium channels subunit 2 (GIRK2) in hippocampus of temporal epileptic rat induced by kainic acid. Chin J Neurol 37, 224-227 (2004)
275. WA Catterall, AL Goldin, SG Waxman: International Union of Pharmacology. XLVII. Nomenclature and structure-Function relationships of voltage-Gated sodium channels. Pharmacol Rev 57, 397-409 (2005)
276. N Agrawal, A Alonso, DS Ragsdale: Increased persistent sodium currents in rat entorhinal cortex layer V neurons in a post-status epilepticus model of temporal lobe epilepsy. Epilepsia 44, 1601-1604 (2003)
277. C Yue, S Remy, H Su, H Beck, Y Yaari: Proximal persistent Na+ channels drive spike afterdepolarizations and associated bursting in adult CA1 pyramidal cells. J Neurosci 25, 9704-9720 (2005)
278. WR Whitaker, RL Faull, M Dragunow, EW Mee, PC Emson, JJ Clare: Changes in the mRNAs encoding voltagegated sodium channel types II and III in human epileptic hippocampus. Neuroscience 106, 275-285 (2001)
279. Z Chen, S Chen, L Chen, J Zhou, Q Dai, L Yang, X Li, L Zhou: Long-term increasing co-localization of SCN8A and ankyrin-G in rat hippocampal cornu ammonis 1 after pilocarpine induced status epilepticus. Brain Res 1270, 112-120 (2009)
280. F Bartolomei, M Gastaldi, A Massacrier, R Planells, S Nicolas, P Cau: Changes in the mRNAs encoding subtypes I, II and III sodium channel alpha subunits following kainate-induced seizures in rat brain. J Neurocytol 26, 667-678 (1997)
281. E Aronica, D Troost, AJ Rozemuller, B Yankaya, GH Jansen, LL Isom, JA Gorter: Expression and regulation of voltage-Gated sodium channel beta1 subunit protein in human gliosis-Associated pathologies. Acta Neuropathol 105, 515-523 (2003)
282. KL Van Gassen, M de Wit, M Van Kempen, WS Van der Hel, PC Van Rijen, AP Jackson, D Lindhout, PN de Graan: Fippocampal Nabeta3 expression in patients with temporal lobe epilepsy. Epilepsia 50, 957-962 (2009)
283. KL Van Gassen, M de Wit, MJ Koerkamp, MG Rensen, PC Van Rijen, FC Holstege, D Lindhout, PN de Graan: Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 49, 1055-1065 (2008)
284. C Schaub, M Uebachs, H Beck: Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy. Epilepsia 48, 1339-1350 (2007)
285. K Jandova, D Pasler, LL Antonio, C Raue, S Ji, M Njunting, O Kann, R Kovacs, HJ Meencke, EA Cavalheiro, U Heinemann, S Gabriel, TN Lehmann: Carbamazepineresistance in the epileptic dentate gyrus of human hippocampal slices. Brain 129, 3290-3306 (2006)
286. S Remy, S Gabriel, BW Urban, D Dietrich, TN Lehmann, CE Elger, U Heinemann, H Beck: A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53, 469-479 (2003)
287. WA Catterall, E Perez-Reyes, TP Snutch, J Striessnig: International Union of Pharmacology. XLVIII. Nomenclature and structure-Function relationships of voltage-Gated calcium channels. Pharmacol Rev 57, 411-425 (2005)
288. BP Bean: The action potential in mammalian central neurons. Nat Rev Neurosci 8, 451-465 (2007)
289. AJ Becker, J Pitsch, D Sochivko, T Opitz, M Staniek, CC Chen, KP Campbell, S Schoch, Y Yaari, H Beck: Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy. J Neurosci 28, 13341-13353 (2008)
290. JH Xu, L Long, YC Tang, HT Hu, FR Tang: Ca (v)1.2, Ca (v)1.3, and Ca (v)2.1 in the mouse hippocampus during and after pilocarpine-induced status epilepticus. Hippocampus 17, 235-251 (2007)
291. S Vigues, M Gastaldi, C Chabret, A Massacrier, P Cau, J Valmier: Regulation of calcium channel alpha (1A) subunit splice variant mRNAs in kainate-induced temporal lobe epilepsy. Neurobiol Dis 6, 288-301 (1999)
292. A Djamshidian, R Grassl, M Seltenhammer, T Czech, C Baumgartner, M Schmidbauer, W Ulrich, F Zimprich: Altered expression of voltage-Dependent calcium channel alpha (1) subunits in temporal lobe epilepsy with Ammon's horn sclerosis. Neuroscience 111, 57-69 (2002)
293. AA Lie, I Blumcke, SG Volsen, OD Wiestler, CE Elger, H Beck: Distribution of voltage-Dependent calcium channel beta subunits in the hippocampus of patients with temporal lobe epilepsy. Neuroscience 93, 449-456 (1999)
294. RA Bender, SV Soleymani, AL Brewster, ST Nguyen, H Beck, GW Mathern, TZ Baram: Enhanced expression of a specific hyperpolarization-Activated cyclic nucleotidegated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus. J Neurosci 23, 6826-6836 (2003)
295. KL Powell, C Ng, TJ O'Brien, SH Xu, DA Williams, SJ Foote, CA Reid: Decreases in HCN mRNA expression in the hippocampus after kindling and status epilepticus in adult rats. Epilepsia 49, 1686-1695 (2008)
296. U Strauss, MH Kole, AU Brauer, J Pahnke, R Bajorat, A Rolfs, R Nitsch, RA Deisz: An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy. Eur J Neurosci 19, 3048-3058 (2004)
297. T Budde, L Caputi, T Kanyshkova, R Staak, C Abrahamczik, T Munsch, HC Pape: Impaired regulation of thalamic pacemaker channels through an imbalance of subunit expression in absence epilepsy. J Neurosci 25, 9871-9882 (2005)
298. K Chen, I Aradi, N Thon, M Eghbal-Ahmadi, TZ Baram, I Soltesz: Persistently modified h-Channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med 7, 331-337 (2001)
299. M Kuisle, N Wanaverbecq, AL Brewster, SG Frere, D Pinault, TZ Baram, A Luthi: Functional stabilization of weakened thalamic pacemaker channel regulation in rat absence epilepsy. J Physiol 575, 83-100 (2006)
300. F Hofmann, M Biel, UB Kaupp: International Union of Pharmacology. LI. Nomenclature and structure-Function relationships of cyclic nucleotideregulated channels. Pharmacol Rev 57, 455-462 (2005)
301. M Biel, C Wahl-Schott, S Michalakis, X Zong: Fyperpolarization-Activated cation channels: From genes to function. Physiol Rev 89, 847-885 (2009)
302. RB Robinson, SA Siegelbaum: Fyperpolarizationactivated cation currents: From molecules to physiological function. Annu Rev Physiol 65, 453-480 (2003)
303. M Shin, D Brager, TC Jaramillo, D Johnston, DM Chetkovich: Mislocalization of h channel subunits underlies h channelopathy in temporal lobe epilepsy. Neurobiol Dis 32, 26-36 (2008)
304. MM Shah, AE Anderson, V Leung, X Lin, D Johnston: Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 44, 495-508 (2004)
305. D Tsay, JT Dudman, SA Siegelbaum: FCN1 channels constrain synaptically evoked Ca2+ spikes in distal dendrites of CA1 pyramidal neurons. Neuron 56, 1076-1089 (2007)
306. JC Magee: Dendritic hyperpolarization-Activated currents modify the integrative properties of hippocampal CA1 pyramidal neurons. J Neurosci 18, 7613-7624 (1998)
307. G Stuart, N Spruston: Determinants of voltage attenuation in neocortical pyramidal neuron dendrites. J Neurosci 18, 3501-3510 (1998)
308. M Kitayama, H Miyata, M Yano, N Saito, Y Matsuda, T Yamauchi, S Kogure: Ih blockers have a potential of antiepileptic effects. Epilepsia 44, 20-24 (2003)
309. PA Schwartzkroin, DA Prince: Cellular and field potential properties of epileptogenic hippocampal slices. Brain Res 147, 117-130 (1978)
310. S Otoom, LM Tian, KA Alkadhi: Veratridine-treated brain slices: A cellular model for epileptiform activity. Brain Res 789, 150-156 (1998)
311. S Piredda, W Yonekawa, TS Whittingham, HJ Kupferberg: Effects of antiepileptic drugs on pentylenetetrazole-induced epileptiform activity in the in vitro hippocampus. Epilepsia 27, 341-346 (1986)
312. A Konnerth, U Heinemann, Y Yaari: Nonsynaptic epileptogenesis in the mammalian hippocampus in vitro. I. Development of seizurelike activity in low extracellular calcium. J Neurophysiol 56, 409-423 (1986)
313. I Nelken, Y Yaari: The role of interstitial potassium in the generation of low-Calcium hippocampal seizures. Isr J Med Sci 23, 124-131 (1987)
314. G Nyitrai, B Lasztoczi, J Kardos: Glutamate uptake shapes low-Mg2+) induced epileptiform activity in juvenile rat hippocampal slices. Brain Res 1309, 172-178 (2010)
315. R Gutierrez, V Armand, S Schuchmann, U Heinemann: Epileptiform activity induced by low Mg2+ in cultured rat hippocampal slices. Brain Res 815, 294-303 (1999)
316. L Velisek, JP Dreier, PK Stanton, U Heinemann, SL Moshe: Lowering of extracellular pH suppresses low-Mg (2+)-induces seizures in combined entorhinal cortexhippocampal slices. Exp Brain Res 101, 44-52 (1994)
317. J Tian, Y Li, S Yang: Model of stimulus train-induced bursting in rat hippocampal slice and the effect of Lglutamate on it). Hua Xi Yi Ke Da Xue Xue Bao 22, 27-30 (1991)
318. PW Gean, P Shinnick-Gallagher: Characterization of the epileptiform activity induced by magnesium-Free solution in rat amygdala slices: An intracellular study. Exp Neurol 101, 248-255 (1988)
319. SF Traynelis, R Dingledine: Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. J Neurophysiol 59, 259-276 (1988)
320. PA Rutecki, FJ Lebeda, D Johnston: 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. J Neurophysiol 57, 1911-1924 (1987)
321. E Aitchison, SE Weston, A Constanti, BJ Whalley: Anticholinesterase- induced epileptiform activity in immature rat piriform cortex slices, in vitro. Neurosci Lett 473, 252-256 (2010)
322. PK Harrison, RD Sheridan, AC Green, IR Scott, JE Tattersall: A guinea pig hippocampal slice model of organophosphate-induced seizure activity. J Pharmacol Exp Ther 310, 678-686 (2004)
323. MR Pelletier, PL Carlen: Repeated tetanic stimulation in piriform cortex in vitro: Epileptogenesis and pharmacology. J Neurophysiol 76, 4069-4079 (1996)
324. P Varro, R Szemerszky, G Bardos, I Vilagi: Changes in synaptic efficacy and seizure susceptibility in rat brain slices following extremely low-Frequency electromagnetic field exposure. Bioelectromagnetics 30, 631-640 (2009)
325. AJ Lombardo, R Kuzniecky, RE Powers, GB Brown: Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res 35, 84-90 (1996)
326. S Penschuck, JF Bastlund, HS Jensen, TB Stensbol, J Egebjerg, WP Watson: Changes in KCNQ2 immunoreactivity in the amygdala in two rat models of temporal lobe epilepsy. Brain Res Mol Brain Res 141, 66-73 (2005)